Pyrrolderivater som farmasoytiske middel
Forbindelser, sammensetninger og fremgangsmåter for å modulere aktiviteten til reseptorer er tilveiebrakt. Spesielt forbindelser og sammensetninger er tilveiebrakt for modulering av aktiviteten til reseptorer og for behandling, hindring eller lindring av ett eller flere symptomer på sykdom eller for...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | nor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | FLATT BRENTON T NYMAN MICHAEL CHARLES MANN LARRY W MARTIN RICHARD BANNEN LYNNE CANNE DALRYMPLE LISA ESTHER FORSYTH TIMOTHY PATRICK MANN GRACE MURPHY BRETT MOHAN RAJU WU JASON H CHEN JEFF MAC MORRISON B WANG TIE-LIN WONG YONG GU XIAO-HU STEVENS JR WILLIAM C |
| description | Forbindelser, sammensetninger og fremgangsmåter for å modulere aktiviteten til reseptorer er tilveiebrakt. Spesielt forbindelser og sammensetninger er tilveiebrakt for modulering av aktiviteten til reseptorer og for behandling, hindring eller lindring av ett eller flere symptomer på sykdom eller forstyrrelse direkte eller indirekte relatert til aktiviteten til reseptorene.
Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NO20070910LL</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NO20070910LL</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NO20070910LL3</originalsourceid><addsrcrecordid>eNrjZNAIqCwqys9JSS3KLEssSS1SKM7PVUhLLMpNLM6vLMkszk5VyM1MSUnN4WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8X7-RgYG5gaWhgY-PsbEqAEAJzIpSQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pyrrolderivater som farmasoytiske middel</title><source>esp@cenet</source><creator>FLATT BRENTON T ; NYMAN MICHAEL CHARLES ; MANN LARRY W ; MARTIN RICHARD ; BANNEN LYNNE CANNE ; DALRYMPLE LISA ESTHER ; FORSYTH TIMOTHY PATRICK ; MANN GRACE ; MURPHY BRETT ; MOHAN RAJU ; WU JASON H ; CHEN JEFF ; MAC MORRISON B ; WANG TIE-LIN ; WONG YONG ; GU XIAO-HU ; STEVENS JR WILLIAM C</creator><creatorcontrib>FLATT BRENTON T ; NYMAN MICHAEL CHARLES ; MANN LARRY W ; MARTIN RICHARD ; BANNEN LYNNE CANNE ; DALRYMPLE LISA ESTHER ; FORSYTH TIMOTHY PATRICK ; MANN GRACE ; MURPHY BRETT ; MOHAN RAJU ; WU JASON H ; CHEN JEFF ; MAC MORRISON B ; WANG TIE-LIN ; WONG YONG ; GU XIAO-HU ; STEVENS JR WILLIAM C</creatorcontrib><description>Forbindelser, sammensetninger og fremgangsmåter for å modulere aktiviteten til reseptorer er tilveiebrakt. Spesielt forbindelser og sammensetninger er tilveiebrakt for modulering av aktiviteten til reseptorer og for behandling, hindring eller lindring av ett eller flere symptomer på sykdom eller forstyrrelse direkte eller indirekte relatert til aktiviteten til reseptorene.
Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.</description><language>nor</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070426&DB=EPODOC&CC=NO&NR=20070910L$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070426&DB=EPODOC&CC=NO&NR=20070910L$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FLATT BRENTON T</creatorcontrib><creatorcontrib>NYMAN MICHAEL CHARLES</creatorcontrib><creatorcontrib>MANN LARRY W</creatorcontrib><creatorcontrib>MARTIN RICHARD</creatorcontrib><creatorcontrib>BANNEN LYNNE CANNE</creatorcontrib><creatorcontrib>DALRYMPLE LISA ESTHER</creatorcontrib><creatorcontrib>FORSYTH TIMOTHY PATRICK</creatorcontrib><creatorcontrib>MANN GRACE</creatorcontrib><creatorcontrib>MURPHY BRETT</creatorcontrib><creatorcontrib>MOHAN RAJU</creatorcontrib><creatorcontrib>WU JASON H</creatorcontrib><creatorcontrib>CHEN JEFF</creatorcontrib><creatorcontrib>MAC MORRISON B</creatorcontrib><creatorcontrib>WANG TIE-LIN</creatorcontrib><creatorcontrib>WONG YONG</creatorcontrib><creatorcontrib>GU XIAO-HU</creatorcontrib><creatorcontrib>STEVENS JR WILLIAM C</creatorcontrib><title>Pyrrolderivater som farmasoytiske middel</title><description>Forbindelser, sammensetninger og fremgangsmåter for å modulere aktiviteten til reseptorer er tilveiebrakt. Spesielt forbindelser og sammensetninger er tilveiebrakt for modulering av aktiviteten til reseptorer og for behandling, hindring eller lindring av ett eller flere symptomer på sykdom eller forstyrrelse direkte eller indirekte relatert til aktiviteten til reseptorene.
Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAIqCwqys9JSS3KLEssSS1SKM7PVUhLLMpNLM6vLMkszk5VyM1MSUnN4WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8X7-RgYG5gaWhgY-PsbEqAEAJzIpSQ</recordid><startdate>20070426</startdate><enddate>20070426</enddate><creator>FLATT BRENTON T</creator><creator>NYMAN MICHAEL CHARLES</creator><creator>MANN LARRY W</creator><creator>MARTIN RICHARD</creator><creator>BANNEN LYNNE CANNE</creator><creator>DALRYMPLE LISA ESTHER</creator><creator>FORSYTH TIMOTHY PATRICK</creator><creator>MANN GRACE</creator><creator>MURPHY BRETT</creator><creator>MOHAN RAJU</creator><creator>WU JASON H</creator><creator>CHEN JEFF</creator><creator>MAC MORRISON B</creator><creator>WANG TIE-LIN</creator><creator>WONG YONG</creator><creator>GU XIAO-HU</creator><creator>STEVENS JR WILLIAM C</creator><scope>EVB</scope></search><sort><creationdate>20070426</creationdate><title>Pyrrolderivater som farmasoytiske middel</title><author>FLATT BRENTON T ; NYMAN MICHAEL CHARLES ; MANN LARRY W ; MARTIN RICHARD ; BANNEN LYNNE CANNE ; DALRYMPLE LISA ESTHER ; FORSYTH TIMOTHY PATRICK ; MANN GRACE ; MURPHY BRETT ; MOHAN RAJU ; WU JASON H ; CHEN JEFF ; MAC MORRISON B ; WANG TIE-LIN ; WONG YONG ; GU XIAO-HU ; STEVENS JR WILLIAM C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NO20070910LL3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>nor</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>FLATT BRENTON T</creatorcontrib><creatorcontrib>NYMAN MICHAEL CHARLES</creatorcontrib><creatorcontrib>MANN LARRY W</creatorcontrib><creatorcontrib>MARTIN RICHARD</creatorcontrib><creatorcontrib>BANNEN LYNNE CANNE</creatorcontrib><creatorcontrib>DALRYMPLE LISA ESTHER</creatorcontrib><creatorcontrib>FORSYTH TIMOTHY PATRICK</creatorcontrib><creatorcontrib>MANN GRACE</creatorcontrib><creatorcontrib>MURPHY BRETT</creatorcontrib><creatorcontrib>MOHAN RAJU</creatorcontrib><creatorcontrib>WU JASON H</creatorcontrib><creatorcontrib>CHEN JEFF</creatorcontrib><creatorcontrib>MAC MORRISON B</creatorcontrib><creatorcontrib>WANG TIE-LIN</creatorcontrib><creatorcontrib>WONG YONG</creatorcontrib><creatorcontrib>GU XIAO-HU</creatorcontrib><creatorcontrib>STEVENS JR WILLIAM C</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FLATT BRENTON T</au><au>NYMAN MICHAEL CHARLES</au><au>MANN LARRY W</au><au>MARTIN RICHARD</au><au>BANNEN LYNNE CANNE</au><au>DALRYMPLE LISA ESTHER</au><au>FORSYTH TIMOTHY PATRICK</au><au>MANN GRACE</au><au>MURPHY BRETT</au><au>MOHAN RAJU</au><au>WU JASON H</au><au>CHEN JEFF</au><au>MAC MORRISON B</au><au>WANG TIE-LIN</au><au>WONG YONG</au><au>GU XIAO-HU</au><au>STEVENS JR WILLIAM C</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pyrrolderivater som farmasoytiske middel</title><date>2007-04-26</date><risdate>2007</risdate><abstract>Forbindelser, sammensetninger og fremgangsmåter for å modulere aktiviteten til reseptorer er tilveiebrakt. Spesielt forbindelser og sammensetninger er tilveiebrakt for modulering av aktiviteten til reseptorer og for behandling, hindring eller lindring av ett eller flere symptomer på sykdom eller forstyrrelse direkte eller indirekte relatert til aktiviteten til reseptorene.
Compounds, compositions and methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of disease or disorder directly or indirectly related to the activity of the receptors.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | nor |
| recordid | cdi_epo_espacenet_NO20070910LL |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | Pyrrolderivater som farmasoytiske middel |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T03%3A03%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FLATT%20BRENTON%20T&rft.date=2007-04-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENO20070910LL%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |